Alzoubi Islam, Bao Guoqing, Zhang Rong, Loh Christina, Zheng Yuqi, Cherepanoff Svetlana, Gracie Gary, Lee Maggie, Kuligowski Michael, Alexander Kimberley L, Buckland Michael E, Wang Xiuying, Graeber Manuel B
School of Computer Science, The University of Sydney, J12/1 Cleveland St, Sydney, NSW 2008, Australia.
Ken Parker Brain Tumour Research Laboratories, Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW 2050, Australia.
Cancers (Basel). 2022 Jul 15;14(14):3441. doi: 10.3390/cancers14143441.
Routine examination of entire histological slides at cellular resolution poses a significant if not insurmountable challenge to human observers. However, high-resolution data such as the cellular distribution of proteins in tissues, e.g., those obtained following immunochemical staining, are highly desirable. Our present study extends the applicability of the PathoFusion framework to the cellular level. We illustrate our approach using the detection of CD276 immunoreactive cells in glioblastoma as an example. Following automatic identification by means of PathoFusion's bifocal convolutional neural network (BCNN) model, individual cells are automatically profiled and counted. Only discriminable cells selected through data filtering and thresholding were segmented for cell-level analysis. Subsequently, we converted the detection signals into the corresponding heatmaps visualizing the distribution of the detected cells in entire whole-slide images of adjacent H&E-stained sections using the Discrete Wavelet Transform (DWT). Our results demonstrate that PathoFusion is capable of autonomously detecting and counting individual immunochemically labelled cells with a high prediction performance of 0.992 AUC and 97.7% accuracy. The data can be used for whole-slide cross-modality analyses, e.g., relationships between immunochemical signals and anaplastic histological features. PathoFusion has the potential to be applied to additional problems that seek to correlate heterogeneous data streams and to serve as a clinically applicable, weakly supervised system for histological image analyses in (neuro)pathology.
以细胞分辨率对整个组织学切片进行常规检查,即便并非无法克服,也对人类观察者构成了重大挑战。然而,诸如组织中蛋白质的细胞分布等高分辨率数据,例如免疫化学染色后获得的数据,是非常需要的。我们目前的研究将PathoFusion框架的适用性扩展到了细胞层面。我们以胶质母细胞瘤中CD276免疫反应性细胞的检测为例来说明我们的方法。通过PathoFusion的双焦点卷积神经网络(BCNN)模型进行自动识别后,对单个细胞进行自动分析和计数。仅对通过数据过滤和阈值处理选择出的可区分细胞进行分割以进行细胞层面分析。随后,我们使用离散小波变换(DWT)将检测信号转换为相应的热图,以可视化检测到的细胞在相邻苏木精-伊红(H&E)染色切片的全切片图像中的分布。我们的结果表明,PathoFusion能够自主检测和计数单个免疫化学标记的细胞,预测性能高达0.992的曲线下面积(AUC)和97.7%的准确率。这些数据可用于全切片跨模态分析,例如免疫化学信号与间变组织学特征之间的关系。PathoFusion有潜力应用于其他旨在关联异质数据流的问题,并作为一种临床适用的弱监督系统用于(神经)病理学中的组织学图像分析。